Related Experiment Videos
Antibacterial activity of quinolone-macrocycle conjugates
Elizabeth A Jefferson1, Eric E Swayze, Stephen A Osgood
1Ibis Therapeutics, A Division of Isis Pharmaceuticals, Inc., 2292 Faraday Avenue, Carlsbad, CA 92008, USA. ejeffers@isisph.com
Bioorganic & Medicinal Chemistry Letters
|May 6, 2003
Summary
Novel quinolone-macrocycle conjugates show potent antibacterial effects against common pathogens like Escherichia coli and Staphylococcus aureus. The cyclic structure is crucial for this activity, as an open-chain version lacked efficacy.
Area of Science:
- Medicinal Chemistry
- Organic Chemistry
- Microbiology
Background:
- Quinolones are a class of synthetic antibacterial agents.
- Macrocycles are large ring structures with diverse biological activities.
- Conjugating different chemical entities can lead to novel therapeutic properties.
Purpose of the Study:
- To synthesize and evaluate novel quinolone-macrocycle conjugates for antibacterial activity.
- To investigate the structure-activity relationship, specifically the role of the macrocyclic structure.
Main Methods:
- Synthesis of quinolone-macrocycle conjugates.
- Antibacterial activity testing against bacterial strains like Escherichia coli and Staphylococcus aureus.
- Comparison with an analogous open-chain structure.
Main Results:
- The novel quinolone-macrocycle conjugates exhibited significant antibacterial activity, with submicromolar potency.
- Escherichia coli and Staphylococcus aureus were susceptible to the conjugates.
- An analogous open-chain compound showed no significant activity at 100 microM.
Conclusions:
- Quinolone-macrocycle conjugation creates potent antibacterial agents.
- The macrocyclic structure is essential for the observed antibacterial efficacy.
- These findings suggest a promising new class of antibiotics for combating bacterial infections.